To enhance its presence in regions like Europe, the Middle East, Africa and the Asia Pacific, CME Group, one of the world’s prominent derivatives marketplaces, announced a new regional leadership structure today. Several leading names in the financial services sector will strengthen the Group’s mission of global expansion.

CME Group noted that Michel Everaert has been named as the Managing Director and Head of EMEA. He joined CME in 2011 and collectively has nearly three decades of experience in the derivatives market. Everaert previously worked with companies like IMEX Group, GFI Group, Logica, Reuters and Dow Jones.

Russell Beattie, an industry veteran with more than 25 years of experience in the listed and OTC derivatives market, will become a part of the CME Group in May this year as the Managing Director and Head of Asia Pacific.

"After record volume growth in EMEA and the Asia Pacific for each of the past 10 years, approximately 30% of our revenue is now generated from non-U.S. markets. Building on that momentum, the organizational changes announced today further elevate both the significance and opportunities that these regions represent to our overall business and reflect the many achievements of our talented regional team members,” Derek Sammann, the Senior Managing Director and Global Head of Commodities, Options and International Markets at CME Group, said.

International Growth

Outside the US, CME Group reported record growth in the average daily volume (ADV) during the first quarter of 2022. The performance was driven by strong growth in regions like EMEA and the Asia Pacific.

To drive its expansion, CME Group has announced the appointment of Serge Marston as Managing Director and Head of CD&S for EMEA, responsible for leading CME Group's sales efforts in the region across both listed derivatives and cash markets.

To enhance its presence in regions like Europe, the Middle East, Africa and the Asia Pacific, CME Group, one of the world’s prominent derivatives marketplaces, announced a new regional leadership structure today. Several leading names in the financial services sector will strengthen the Group’s mission of global expansion.

CME Group noted that Michel Everaert has been named as the Managing Director and Head of EMEA. He joined CME in 2011 and collectively has nearly three decades of experience in the derivatives market. Everaert previously worked with companies like IMEX Group, GFI Group, Logica, Reuters and Dow Jones.

Russell Beattie, an industry veteran with more than 25 years of experience in the listed and OTC derivatives market, will become a part of the CME Group in May this year as the Managing Director and Head of Asia Pacific.

"After record volume growth in EMEA and the Asia Pacific for each of the past 10 years, approximately 30% of our revenue is now generated from non-U.S. markets. Building on that momentum, the organizational changes announced today further elevate both the significance and opportunities that these regions represent to our overall business and reflect the many achievements of our talented regional team members,” Derek Sammann, the Senior Managing Director and Global Head of Commodities, Options and International Markets at CME Group, said.

International Growth

Outside the US, CME Group reported record growth in the average daily volume (ADV) during the first quarter of 2022. The performance was driven by strong growth in regions like EMEA and the Asia Pacific.

To drive its expansion, CME Group has announced the appointment of Serge Marston as Managing Director and Head of CD&S for EMEA, responsible for leading CME Group's sales efforts in the region across both listed derivatives and cash markets.